Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

NCT03356483 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Psilocybin (0.25mg/kg)
DRUG: Niacin (250mg)

Sponsor

Yale University

Collaborators

[object Object]
[object Object]